) was a big mover last session with shares rising nearly 13% on the
day. The move came on solid volume too with far more shares
changing hands than in a normal session. This continues the recent
uptrend for the company, as the stock is now up over 30% in the
past one-month time frame.
This biopharmaceutical company has seen no estimate revision in the
last 30 days. The Zacks Consensus Estimate has also remained
unchanged over the same period. Yesterday's rally is encouraging
though, so make sure to keep a close watch on this firm in the near
Receptos currently has a Zacks Rank #4 (Sell) while its
However, better-ranked Med-Drug stocks include
Jazz Pharmaceuticals plc
Sagent Pharmaceuticals, Inc.
). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
JAZZ PHARMACEUT (JAZZ): Free Stock Analysis
RECEPTOS INC (RCPT): Free Stock Analysis Report
SAGENT PHARMA (SGNT): Free Stock Analysis
ZOGENIX INC (ZGNX): Free Stock Analysis Report
To read this article on Zacks.com click here.